SCHEMBL10155082

SCHEMBL10155082

COC(=O)C/N=C(\C)c1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.68
CYP2D6 P10635 1/20 0.68
HSD17B10 Q99714 1/20 0.68
LMNA P02545 3/20 0.50
MAPK1 P28482 2/20 0.50
HTT P42858 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
MAPT P10636 4/20 0.49
POLB P06746 2/20 0.49
TSHR P16473 1/20 0.47
ALDH1A1 P00352 3/20 0.46
ESRRB O95718 1/20 0.45
AKT1 P31749 1/20 0.44
HPGD P15428 2/20 0.43
PKM P14618 2/20 0.43
CDK5 Q00535 1/20 0.43
CDK5R1 Q15078 1/20 0.43
KDM4E B2RXH2 2/20 0.41
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2738356 1.00 CYP1A2 (0.68) CYP1A2CYP2D6HSD17B10LMNAMAPK1
SCHEMBL478673 0.84 TSHR (0.48) CYP1A2CYP2D6HSD17B10LMNAMAPK1
SCHEMBL14542586 0.83 CYP1A2 (0.64) CYP1A2CYP2D6HSD17B10LMNAMAPK1
SCHEMBL11116388 0.83 CYP1A2 (0.64) CYP1A2CYP2D6HSD17B10LMNAMAPK1
SCHEMBL11116386 0.83 CYP1A2 (0.64) CYP1A2CYP2D6HSD17B10LMNAMAPK1
SCHEMBL14286180 0.81 CYP1A2 (1.00) CYP1A2CYP2D6HSD17B10LMNAMAPK1
SCHEMBL17489043 0.81 CYP1A2 (1.00) CYP1A2CYP2D6HSD17B10LMNAMAPK1
SCHEMBL14542242 0.78 HSD17B10 (0.57) CYP1A2CYP2D6HSD17B10LMNAMAPK1
SCHEMBL22143556 0.75 CYP1A2 (0.53) CYP1A2CYP2D6HSD17B10LMNAMAPK1
SCHEMBL12511943 0.73 L3MBTL1 (0.56) CYP1A2CYP2D6HSD17B10LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1687018-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2012-01-25 EP disclosed
US-7741281-B2 Hepatitis C virus inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2010-06-22 US disclosed